Clean Cells, established in 2000 and based in Montaigu-Vendée, France, is a CRO/CDMO specializing in biopharmaceuticals. The company's services include GMP cell and virus bank manufacturing, biosafety testing, product characterization, and secure storage solutions. In 2023, Clean Cells opened a state-of-the-art, 5,300-sq.-m. facility, significantly enhancing its capacity, positioning itself as one of Europe's largest biopharmaceutical testing sites. As part of the Clean Biologics group, Clean Cells collaborates closely with its sister company Naobios to provide integrated services that support the development of innovative therapies and personalized medicine.